Cargando…
Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
BACKGROUND: Clinical studies have suggested that prostate health index (phi) outperforms prostate-specific antigen (PSA) tests in prostate cancer detection. The cost-effectiveness of phi with different cutoffs is poorly understood in the context of decision making for prostate biopsy. METHODS: In a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732507/ https://www.ncbi.nlm.nih.gov/pubmed/33330035 http://dx.doi.org/10.3389/fonc.2020.565382 |